(Q34598512)

English

Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations

scholarly article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations (English)

1 reference

Europe PubMed Central

3 August 2017

0 references

0 references

latent tuberculosis

1 reference

based on heuristic

inferred from title

0 references

Rochelle P. Walensky

3

1 reference

Europe PubMed Central

3 August 2017

2

object named as

Marc Lipsitch

0 references

object named as

Ted Cohen

1

0 references

author name string

Megan Murray

4

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

21 April 2006

1 reference

Europe PubMed Central

3 August 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

3 August 2017

103

1 reference

Europe PubMed Central

3 August 2017

18

1 reference

Europe PubMed Central

3 August 2017

7042-7047

1 reference

Europe PubMed Central

3 August 2017

Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Tuberculosis control in the era of HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patterns

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

A re-examination of the potential impact of preventive therapy on the public health problem of tuberculosis in contemporary sub-Saharan Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Treatment of latent tuberculosis infection in HIV infected persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Tuberculosis epidemics driven by HIV: is prevention better than cure?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

The effect of drug resistance on the fitness of Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Antimicrobial use and antimicrobial resistance: a population perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Criteria for the control of drug-resistant tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Modeling the impact of global tuberculosis control strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Control strategies for tuberculosis epidemics: new models for old problems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Modelling the efficacy of prophylactic and curative therapies for preventing the spread of tuberculosis in Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

The intrinsic transmission dynamics of tuberculosis epidemics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Controlled chemoprophylaxis trials in tuberculosis. A general review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Potential of community-wide chemotherapy or immunotherapy to control the spread of HIV-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Modeling zidovudine therapy: a cost-effectiveness analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

7 July 2018

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

Patients with active tuberculosis often have different strains in the same sputum specimen

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

Understanding, predicting and controlling the emergence of drug-resistant tuberculosis: a theoretical framework

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

Effect of drug resistance on the generation of secondary cases of tuberculosis

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

Does DOTS work in populations with drug-resistant tuberculosis?

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

Early therapy for latent tuberculosis infection.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

Evolution of Tuberculosis Control and Prospects for Reducing Tuberculosis Incidence, Prevalence, and Deaths Globally

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

The reinfection threshold promotes variability in tuberculosis epidemiology and vaccine efficacy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

26 October 2018

Will tuberculosis become resistant to all antibiotics?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459015

26 October 2018

Exogenous reinfection in tuberculosis

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

In Vivo Phenotypic Dominance in Mouse Mixed Infections withMycobacterium tuberculosisClinical Isolates

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0600349103

21 January 2018

Evaluation of tuberculosis control policies using computer simulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16632605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.0600349103

1 reference

Europe PubMed Central

3 August 2017

2006PNAS..103.7042C

0 references

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34598512&oldid=1647502157"